HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can an app help cancer patients kick the habit? new trial says yes
Disease control OngoingThis study tests whether a smartphone app called Quit2Heal can help cancer patients quit smoking better than another app called QuitGuide. About 427 adults with cancer who smoke will use one of the two apps for support. The main goal is to see how many people can stay smoke-free …
Matched conditions: HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New vaccine hope for blood cancer patients after transplant
Disease control OngoingThis study is for people with blood cancers like leukemia or lymphoma who have had a stem cell transplant or cell therapy. It tests a new COVID-19 vaccine (GEO-CM04S1) to see if it provides better protection against COVID-19 than the standard mRNA vaccines. The goal is to help th…
Matched conditions: HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: GeoVax, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Can a single drug stop transplant rejection? new trial hopes to find out
Disease control OngoingThis study tests whether the drug ustekinumab can prevent acute graft-versus-host disease (GVHD) in adults receiving a stem cell transplant from an unrelated donor for blood cancers. GVHD occurs when donor cells attack the patient's body. Ustekinumab aims to calm the immune syste…
Matched conditions: HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
New combo targets cancer fatigue: exercise plus steroid shows promise
Symptom relief OngoingThis study tests whether adding a steroid drug called dexamethasone to a physical activity program can better reduce severe fatigue in people with advanced cancer. About 99 participants will be assigned to exercise alone or exercise plus the drug. The goal is to see if the combin…
Matched conditions: HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 11, 2026 20:49 UTC
-
Tuning in to calm: music may reduce biopsy anxiety
Symptom relief OngoingThis study tests whether listening to music during a bone marrow biopsy or aspiration can lower anxiety. About 113 adults with blood cancers will be randomly assigned to either receive standard care or also listen to music during the procedure. Researchers will measure anxiety le…
Matched conditions: HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM
Phase: PHASE3 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 06, 2026 16:01 UTC
-
New study tests Full-Body scans and blood tests to catch cancer early in High-Risk families
Knowledge-focused OngoingThis study looks at whether whole body MRI scans and liquid biopsies (blood tests) are acceptable and useful for finding early cancer in 100 people aged 50 or older who have a strong family history of cancer. Participants will have these tests and answer questions about their exp…
Matched conditions: HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM
Phase: EARLY_PHASE1 • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC
-
What happens to your facebook when you die? cancer patients share their wishes
Knowledge-focused OngoingThis study surveys 117 advanced cancer patients to learn if they have talked with family about managing their social media accounts after death. The goal is to understand patient needs and reduce stress around digital legacy. Participants are adults who have used social media and…
Matched conditions: HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC
-
New scanner aims to cut cancer scans in half
Knowledge-focused TerminatedThis study compares a new PET-CT scanner (RefleXion) to the standard one for people with various cancers. About 20 adults will get both scans to see if the new one finds the same tumors. If it works well, patients may need fewer scans before radiation therapy.
Matched conditions: HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC